De Ponti C, Ciliberto R, Sozzi G, Foti F A, Rovelli F
G Ital Cardiol. 1976;6(7):1238-45.
The efficacy and duration of the effects of verapamil on angina threshold during exercise were examined in five patients with proved angina pectoris, with the experimental model of a latin square 5 X 5. The effects of verapamil (0,1 mg/kg i.v.) were compared with those of a placebo (20 ml saline i.v.), of isosorbide dinitrate (5 mg, sublingual), of propranolol (0,1 mg/kg i.v.), and of dipyridamol (20 mg i.v.). All the treatments were studied within 20 minutes after administration; the efficacy of the "drugs" was checked against placebo. Verapamil and isosorbide dinitrate significantly prolonged the duration of exercise and total amount of work done before angina and EKG alteration appearance. Similar changes were observed after propranolol, but not significantly different from the effects of placebo. Dipyridamol reduced thw work performance, without significant difference from placebo. The effects of verapamil, though less marked than its peak effects, were still present 70 minutes after administration. The possible mechanism of work performance improvements induced by verapamil in angina pectoris is briefly discussed on the basis of the Triple Product changes observed during exercise.
采用5×5拉丁方实验模型,对5例确诊为心绞痛的患者,研究了维拉帕米对运动中心绞痛阈值的疗效及作用持续时间。将维拉帕米(0.1mg/kg静脉注射)的效果与安慰剂(20ml生理盐水静脉注射)、硝酸异山梨酯(5mg,舌下含服)、普萘洛尔(0.1mg/kg静脉注射)和双嘧达莫(20mg静脉注射)的效果进行了比较。所有治疗均在给药后20分钟内进行研究;“药物”的疗效与安慰剂对照检查。维拉帕米和硝酸异山梨酯显著延长了运动持续时间以及心绞痛和心电图改变出现前完成的总工作量。普萘洛尔治疗后也观察到类似变化,但与安慰剂效果无显著差异。双嘧达莫降低了工作表现,与安慰剂无显著差异。维拉帕米的效果虽然不如其峰值效果明显,但在给药70分钟后仍然存在。基于运动期间观察到的三联乘积变化,简要讨论了维拉帕米改善心绞痛患者工作表现的可能机制。